Biotechnology News

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the appointment of Hugh M. Cole to the position of senior vice president and chief business officer. Mr. Cole will be responsible for global business...

April 2, 2014

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that they have submitted the final study report for the Phase 1 study comparing the...

April 2, 2014

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Newborn Screening Solution from AB SCIEX Provides Early Detection Indicators of Metabolic Disorders to Help Doctors in Europe Make Babies’ Health More Predictable

April 2, 2014

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (OMX Nordic Exchange: AERO)(STO:AERO-B) today announced that NICE (National Institute for Health and Care Excellence) has published guidelines (...

April 2, 2014

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, an innovative molecular information company, announces a new comprehensive epilepsy sequencing test designed to sequence 489 genes known to be involved in epilepsy, antiepileptic drug...

April 2, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. The new name better reflects the company’s strong position as a late-stage, purpose-built...

April 2, 2014

ORLANDO, Fla.--(BUSINESS WIRE)--On April 7, 2014, Mazor Robotics (TASE:MZOR; NASDAQ GM:MZOR) will debut and officially launch the new Renaissance Guidance System brain module at the American Association of Neurological Surgeons (AANS) annual...

April 2, 2014

LEE’S SUMMIT, Mo.--(BUSINESS WIRE)--Acceleration earns four out of five 2014 CRO Leadership Awards from Life Science Leader in the categories of Regulatory, Innovation, Productivity and Reliability.

April 2, 2014

LUXEMBOURG--(BUSINESS WIRE)--Advanced Biological Laboratories S.A. enters into exclusive licensing agreement with CRP-Santé for “COMET” software a tool designed for high performance DNA sequencing analysis and classification.

April 2, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina expands its product portfolio to support oncology clinical research and discovery. The next-generation sequencing and array portfolio supports cancer research and other applications.

April 2, 2014

SOLNA, Sweden--(BUSINESS WIRE)--Notice is hereby given that the Annual General Meeting (AGM) of Meda AB (STO:MEDAA), corporate ID 556427-2812, will be held at 5.00 PM on Wednesday, May 7, 2014 at Meda’s headquarters at Pipers väg 2A, Solna,...

April 2, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the first quarter of 2014 after market close on Thursday May 1, 2014. The company will hold a conference call on the...

April 2, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals' PV-10 Data to Feature in Poster Presentation by Moffitt Cancer Center at ASCO

April 2, 2014

NIJMEGEN, Netherlands--(BUSINESS WIRE)--Synthon Biopharmaceuticals today announced the results of a head-to-head comparative program of its ADC SYD985 with Roche’s market leading anti-HER2 ADC, T-DM1 (Kadcyla®*).

April 2, 2014

STOCKHOLM--(BUSINESS WIRE)--The US Food and Drug Administration (FDA) has cleared the neuropsychological test – QbTest – developed by the Swedish company Qbtech to aid in the evaluation of treatment interventions in patients with ADHD. QbTest is...

April 2, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN) today announced that GlaxoSmithKline’s (NYSE: GSK) MAGRITi study, a Phase 3 randomized, blinded, placebo-controlled MAGE-A3ii cancer immunotherapeutic trial in non-small cell lung...

April 2, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announces an exclusive supply and license agreement for...

April 2, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet...

April 2, 2014

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (Paris:ERF) (EUFI.PA), the global leader in bio-analytical testing, and one of the world leaders in genomic services, announces that it is combining its competencies to provide the...

April 2, 2014

WASHINGTON--(BUSINESS WIRE)--The world’s leading researchers in the field of traumatic brain injury research are meeting on April 16 & 17, 2014 in Washington DC for the 4th Annual Traumatic Brain Injury Conference.

April 2, 2014

LENOIR, N.C.--(BUSINESS WIRE)--GREER® Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced that the U.S. Food and Drug Administration (FDA) has approved ORALAIR® (Sweet Vernal,...

April 1, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC), a leader in the field of regenerative medicine, announced today that it filed its annual report on Form 10-K for the year ended December 31, 2013. The...

April 1, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that Maxine Gowen, Ph.D.,...

April 1, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that it has issued inducement awards to three new non-executive employees. The awards were made on March 31, 2014 under...

April 1, 2014

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX:NDN) (NYSE:NDZ), announced today that the Ontario Superior Court of Justice has granted an order extending the time for calling and holding the Company’s annual general meeting (the "AGM"),...

April 1, 2014

BOULDER, Colo.--(BUSINESS WIRE)--SomaLogic, Inc., announced today that Dan Muehl has joined the company as Chief Financial Officer (CFO). “I am delighted that Dan has agreed to join us during this critical growth period for SomaLogic,” said Byron...

April 1, 2014

MINNEAPOLIS--(BUSINESS WIRE)--Starkey Hearing Technologies, one of the world’s leading hearing technology companies, is excited to announce that the Oprah Winfrey Network (OWN) will air Operation Change, a television documentary series that...

April 1, 2014

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the year 2013....

April 1, 2014

SEOUL, South Korea--(BUSINESS WIRE)--Family owned, Austrian company CROMA-PHARMA announced today the signing of a 10 year comprehensive and important distribution agreement with Hugel Inc. of Korea. Hugel Inc. is the leading producer of anti-...

April 1, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, updates on Loramyc®/Oravig® development programs by its...

April 1, 2014

MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Tuesday, April 22, 2014 at 5:00 PM EDT, to discuss the company’s first quarter 2014 operating results, and to provide financial...

April 1, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (the “Company”) (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care diagnostics that helps patients and physicians better manage chronic...

April 1, 2014

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VertiFlex®, Inc. announces submission of final PMA module to the FDA, for the Superion® Interspinous Spacer System

April 1, 2014

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Source BioScience plc, the international laboratory services and products business, today announces the launch of its US business, operating out of facilities in Santa Fe Springs and Atlanta.

April 1, 2014

HORSHAM, Pa.--(BUSINESS WIRE)--DIA 2014 50th Annual Meeting to Address Global Debate About Biosimilars. Experts in industry, research and pharma will discuss complex drug market and regulation.

April 1, 2014

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) today announced the appointment of Adam Logal as Senior Vice President, Chief Financial Officer. Additionally, Arie Gutman Ph.D. was appointed Chief Executive Officer of OPKO’s newly created...

April 1, 2014

DENVER--(BUSINESS WIRE)--New clinical trial results show Corgenix Medical rapid diagnostic test greatly reduces time-to-diagnosis for patients possibly infected with Lassa fever virus.

April 1, 2014

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--EAGLE PHARMACEUTICALS’ EXCLUSIVE LICENSOR GRANTED US PATENT FOR DANTROLENE IN THE TREATMENT OF HEAT STROKE

April 1, 2014

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics announced today that an updated accredited, self-learning program entitled, “Reducing Heart Failure Readmissions: Case Studies Utilizing Biomarkers for Risk Stratification,” is available now online...

April 1, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide announced today that Nexstim, a leader in navigated stimulation of the brain, has selected the company to manage the US-based clinical trial for its Navigated Brain Therapy System.

April 1, 2014

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Announce Results for First Quarter 2014 on April 29

April 1, 2014

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC) announced today the addition of Timothy Pearson to its Board of Directors. Mr. Pearson most recently held the position of Chief Financial Officer, Executive Vice President and...

April 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea has been added to the Russell 3000® and Russell 2000® Indices.

April 1, 2014

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central...

April 1, 2014

PLYMOUTH, Minn.--(BUSINESS WIRE)--Rotation Medical received 510(k) clearance for its implantable collagen scaffold technology for treating totator cuff disease

April 1, 2014

ST. LOUIS--(BUSINESS WIRE)--Perficient has acquired BioPharm Systems, Inc., a $15 million annual services revenue business and information technology consulting firm focused on the life sciences industry.

April 1, 2014

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) will host a conference call and live audio webcast on Thursday, April 24, 2014 at 9 a.m. ET to discuss first quarter 2014 financial and operational results. The webcast can be...